|
![]() |
Biomediation > Antibody
The following information is about Antibody.
Antibody Defined
Any of the body globulins that combine specifically with antigens and neutralize toxins, agglutinate bacteria or cells, and precipitate soluble antigens.
This definition is in context to Biomediation. See more contextual defintions for Antibody.
Laureate Pharma Presents Best Practices In Manufacturing Fusion Proteins At The September 2008 Bioprocess ...
Published August 20, 2008, 6:32 am, BioresearchOnline
Laureate Pharma, Inc., a full service contract manufacturer (CMO) and a provider of development and cGMP bioprocessing services in Princeton, New Jersey announces a presentation in conjunction with Enobia, a biopharmaceutical company dedicated to treating rare and severe genetic bone-growth disorders
Morphotek ties up with NCI for development of monoclonal antibody for prostate cancer
Published August 20, 2008, 1:43 am, PharmaBiz
Morphotek Inc, a subsidiary of Eisai Corporation of North America, has signed a license agreement with the National Cancer Institute (NCI) for the rights to a monoclonal antibody for a novel antigen identified by NCI researchers.
Biodesign Institute & ImmuneRegen collaborate to evaluate effectiveness of Viprovex
Published August 19, 2008, 10:43 pm, PharmaBiz
ImmuneRegen BioSciences, Inc, a wholly-owned subsidiary of IR BioSciences Holdings, Inc announced a collaborative relationship with the Biodesign Institute at Arizona State University (ASU), Tempe, Ariz, to evaluate the effectiveness of ImmuneRegen's Viprovex in boosting the immune response, when used as an adjuvant in conjunction with unique plant-derived vaccines against noroviruses (also ...
Sigma-Aldrich and Atlas Antibodies Announce the Release of 2,000 New, Highly-Validated Prestige Antibodies
Published August 19, 2008, 1:00 pm, PR Newswire via Yahoo! Finance
Sigma-Aldrich today announced the addition of over 2,000 antibodies to its line of Prestige Antibodies.
Prostate Cancer Foundation Commits $4.3 Million to Young Investigators
Published August 19, 2008, 9:33 am, Centre Daily Times
The Prostate Cancer Foundation (PCF) today announced 19 Young Investigators Awards for 2008. Designed to encourage the most innovative research thinkers to continue their careers in prostate cancer research, the awards provide recipients with $75,000 annually for three years to support specified research programs. These awards, totaling $225,000 each, are matched by the recipients' institutions. ...
Prostate Cancer Foundation Commits $4.3 Million to Young Investigators
Published August 19, 2008, 5:00 am, Business Wire via Yahoo! Finance
SANTA MONICA, Calif.----The Prostate Cancer Foundation today announced 19 Young Investigators Awards for 2008. Designed to encourage the most innovative research thinkers to continue their careers in prostate cancer research, the awards provide recipients with $75,000 annually for three years to support specified research programs.
Global phase-3 study of IMC-1121B in metastatic breast cancer commences
Published August 19, 2008, 3:43 am, PharmaBiz
ImClone Systems Incorporated, a global leader in the development and commercialization of novel antibodies to treat cancer, announced that the first patient has been treated in a global phase-3 clinical trial of IMC-1121B, its anti-vascular endothelial growth factor receptor-2 (VEGFR-2) IgG1 monoclonal antibody, in women with metastatic breast cancer.
ASU's Biodesign Institute And ImmuneRegen Collaborate To Investigate Possible Enhancement Of Vaccine Against Norwalk ...
Published August 19, 2008, 3:14 am, Medical News Today
ImmuneRegen® BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB: IRBS), announced a collaborative relationship with the Biodesign Institute at Arizona State University (ASU), Tempe, Ariz.
News briefs
Published August 19, 2008, 12:14 am, Rochester Democrat and Chronicle
Gardner will advise Paterson URMC-studied drug approved Man charged in ATV fatality Wilmot doctor gets $1.6M grant
Elderly Survivors Of 1918 Flu Enable Resurrection Of Antibodies
Published August 18, 2008, 6:13 am, Medical News Today
Ninety years after the sweeping destruction of the 1918 flu pandemic, researchers at Monroe Carell Jr. Children's Hospital at Vanderbilt have recovered antibodies to the virus - from elderly survivors of the original outbreak.
Are you looking for additional Biomediation > Antibody news? Try our new "Antibody News Focus" area.
Off-site Antibody Links, User Submitted
The following links have been collected through user bookmark submission in the Antibody category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Thu Aug 21
Mon Aug 18
- Remembrance of viruses past : Nature News
- www.bioinf.org .uk : Dr. Andrew C.R. Martin's Group at UCL: This page provides an automatically updated summary of all antibody structures in the Protein Databank
- TheStar.com | News & Features | Antibodies from 1918 flu still work well, study says
Sun Aug 17
Fri Aug 15
Wed Aug 13
Mon Aug 11
- Antibody Directory | A resource portal for monoclonal & polyclonal antibodies
- Antibodies - Biocompare Buyer's Guide
- antibodies-onl ine.com - The Marketplace for Antibodies
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Antibody. If you would like to find related tags we recommend Tag Patterns > Antibody
Off-site Antibody Research Links
If you still need additional information on Antibody then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Biomediation Topics
Everything you need to know about Biomediation
Biomediation
If you know the Biomediation Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Biomediation.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.
